Bilirubin breakdown via photooxidation

Bilirubin breakdown via photooxidation" is not a canonical molecular target such as a receptor, enzyme, transporter, or a discrete protein. Instead, it describes a chemical process or series of reactions in which **bilirubin**, a tetrapyrrole product of heme metabolism, undergoes degradation when exposed to light. This process is exploited in **phototherapy** for neonatal jaundice (hyperbilirubinemia), where light initiates photoisomerization of bilirubin followed by **photooxidation**, producing degradation products such as biliverdin and further oxidized metabolites[1][2]. The process is not mediated by a single protein or molecular target, but rather by direct interaction between light photons and bilirubin molecules—possibly facilitated by endogenous photosensitizers like riboflavin[1]. Therefore, this is a physiological or therapeutic process and not an established drug target or specific molecule. For these reasons, this entry does not correspond to a traditional single molecular target; instead, it refers to a **biochemical reaction/mechanism** applied in medical treatment, most notably for **neonatal jaundice**. There is nothing actually misspelled, but it is classified as incorrect in this context because it does not fit molecular target conventions.

Other names

Photodegradation of bilirubinBilirubin phototherapy pathwayBilirubin photoisomerization and photooxidation